Effect of soft tissue augmentation with autologeous epithelialized connective tissue grafts in the treatment of periimplantitis: A randomised controlled clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00032251

Enrollment

Registered

2023-07-11

Start date

2023-07-04

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K10.9

Interventions

Group 1: Screening evaluations • Study inclusion and exclusion criteria • Panoramic radiograph or a CBCT or a single tooth radiograph • informed consent • Clinical measurements of PPD, BOP, HKT • subg

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Periimplantitis (Renvert et. al. 2018), less than 2mm keratinized periimplant mucosa or periimplant mucosa non-attached, healthy patient (ASA I-II), non-smoker, good oral hygiene, able to follow study protocol, periodontally healthy

Exclusion criteria

Exclusion criteria: pregnant, implant mobility, irrational to treat implant (>80% bone loss), more than 2mm keratinized periimplant mucosa that is attached at the same time

Design outcomes

Primary

Measure	Time frame
Implant survival and success periimplantitis treatment after 12,24,60 months according to Herrera et. al. 2023	—

Secondary

Measure	Time frame
After 12,24,60 months after therapy periimplant mucositis, periodontal probing depths, attachment level, dimensional changes of epithelialized free gingival graft, width of keratinized mucosa, 3-dimensional evaluation of periimplant defect	—

Countries

Germany

Contacts

Public ContactPhilip Stähler

Mund-Kiefer-Gesichtschirurgie der LMU

philip.staehler@med.uni-muenchen.de+4989440052971

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026